Acadia Pharmaceuticals | ACAD - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
ALKERMES USD 8.73B 2.85B 2026-06
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Cara Therapeutics USD 30M 336M 2026-03
Corcept Therapeutics USD 9.33B 5.02B 2026-06
Cytokinetics USD 11.55B 3.36B 2026-06
Eisai JPY 1.2T 219.32B 2026-06
Eli Lilly USD 1.13T 260.54B 2026-06
Incyte USD 22.65B 3.92B 2026-06
J&J USD 611.36B 32.21B 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Prothena USD 516M 2M 2026-03
Sarepta Therapeutics USD 1.9B 388M 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06